Volume | 23,424 |
|
|||||
News | - | ||||||
Day High | 9.97 | Low High |
|||||
Day Low | 9.42 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Annovis Bio Inc | ANVS | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
9.61 | 9.42 | 9.97 | 9.41 | 9.57 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
295 | 23,424 | $ 9.74 | $ 228,145 | - | 9.42 - 23.8881 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:10:00 | 363 | $ 9.41 | USD |
Annovis Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
84.72M | 9.01M | - | 0 | -25.33M | -2.81 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Annovis Bio News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANVS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 10.80 | 11.10 | 9.42 | 10.20 | 76,692 | -1.40 | -12.96% |
1 Month | 12.30 | 12.69 | 9.42 | 10.63 | 42,374 | -2.90 | -23.58% |
3 Months | 14.11 | 15.10 | 9.42 | 12.01 | 28,726 | -4.71 | -33.38% |
6 Months | 19.50 | 23.8881 | 9.42 | 13.92 | 56,226 | -10.10 | -51.79% |
1 Year | 13.15 | 23.8881 | 9.42 | 14.34 | 51,965 | -3.75 | -28.52% |
3 Years | 4.72 | 132.00 | 4.14 | 47.10 | 243,363 | 4.68 | 99.15% |
5 Years | 9.10 | 132.00 | 2.418 | 36.81 | 264,919 | 0.30 | 3.3% |
Annovis Bio Description
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. |